🇰🇷South Korea·AI News·12 Nov 2026·via It비즈뉴스

    DIAGENS Leads Medical AI Benchmarks and Extends Chest and Abdominal CT Analysis to 509 Imaging Targets

    DIAGENS (HKEX: 2526) announced benchmark results for its iMed-6.0 medical AI platform on November 12, 2026. The company states iMed-6.0 applies multimodal reasoning to medical imaging, supporting a multi-task CT model capable of analyzing 509 imaging targets across chest and abdominal CT scans. It also includes zero-code tools for specialized AI development.

    DIAGENS describes its iMed-6.0 platform as an advancement in medical imaging AI, specifically for Computed Tomography (CT) scans. The reported "multimodal reasoning" capability suggests the system can integrate and interpret various data types within medical imaging, though the announcement highlights its application to CT. This approach could offer a more comprehensive analysis than systems relying on a single data stream.

    The platform's ability to power a "multi-task CT model" indicates it can perform several analytical operations simultaneously on CT images. The stated extension to "509 Imaging Targets" for chest and abdominal scans suggests a broad scope of features or conditions the AI is designed to detect or analyze. This breadth could reduce the need for multiple specialized AI models for different anatomical areas or pathologies.

    The inclusion of "zero-code tools" for "specialty AI development" implies that medical professionals or developers without extensive programming knowledge might be able to customize or train the AI for specific, niche applications. This could lower the barrier to entry for developing tailored AI solutions in clinical settings, potentially allowing for more rapid adaptation to evolving diagnostic needs or research questions. The announcement, however, does not detail the nature of the benchmark results or specific performance metrics.

    While DIAGENS describes significant capabilities, the absence of specific benchmark details means the practical efficacy and comparative performance of iMed-6.0 are not yet established through this report. The utility of "zero-code tools" will depend on their flexibility and the specific medical expertise required to effectively customize the AI without programming knowledge.

    Share this article

    Original reporting by It비즈뉴스We don't republish, read the full story →

    Related reading

    6 stories